Abstract
Diffuse optical spectroscopy (DOS) is a technique that leverages light propagation in highly scattering media to measure tissue optical properties. This technique is also commonly referred to as near-infrared spectroscopy (NIRS) when utilizing wavelengths in the near-infrared (NIR) region (∼650 to 1000 nm). DOS and NIRS have been widely applied in medical diagnostics in applications ranging from cancer to neuroscience.1 Three types of NIRS modalities are commonly used in biological measurements: continuous wave (CW), frequency domain (FD), and time domain (TD).1 – 3 Among these techniques, only FD-NIRS and TD-NIRS allow for the decoupling of absolute absorption (μa) and reduced scattering (μs′) from the measured optical signal.4 Specifically, for FD-NIRS, the absolute measurements of both μa and μs′ can be achieved using calibrated amplitude and phase information of the detected light after traveling through tissue.1,5 One of the limitations of FD-NIRS is the added instrumental complexity compared with CW-NIRS, which typically restricts absolute measurements of optical properties to only a few wavelengths simultaneously. To address this, hybrid FD + CW systems have been developed to acquire absolute broadband μa and μs′ spectra.5 – 7 Though prior NIRS techniques have focused on quantifying oxygenated and deoxygenated hemoglobin (HbO2 and Hb, respectively),1,2 there has been a growing interest over the last decade in using diffuse optical techniques to measure tissue concentrations of water and lipids.8 – 11
Funding Information
  • National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (R21DK132784)

This publication has 57 references indexed in Scilit: